In summary, we demonstrate for the first time that knockdown of endogenous PLOD2 suppresses glioma cell proliferation, migration and invasion through modulating multiple EMT-associated factors via inactivation of PI3K/AKT signaling. The gene discussed is PLOD2; the disease is glioma.